MRI Study: Ménière’s vs Vestibular Migraine

A new study from the University of Montreal Hospital Center provides the clearest picture yet of how a specific inner ear finding separates two common and often-confused balance disorders. Using high-resolution MRI to visualize endolymphatic hydrops—a fluid buildup in the inner ear—researchers found distinct patterns in patients with Ménière disease (MD) versus vestibular migraine (VM). Their work, published in Otology & Neurotology, confirms hydrops as a core feature of MD while showing it is often absent in VM, offering a potential roadmap for more precise diagnosis and treatment.

How MRI Is Revealing the Inner Ear’s Secrets

For decades, diagnosing Ménière disease relied on clinical symptoms—episodic vertigo, hearing loss, tinnitus, and a feeling of ear fullness. Vestibular migraine shares many of these features, especially vertigo and headache, leading to frequent misdiagnosis and frustration for patients. The recent ability to visualize endolymphatic hydrops non-invasively with MRI has changed the game. Led by Carolanne Gagnon, Laurent Letourneau, and Issam Saliba, this prospective study aimed to see if hydrops patterns could reliably tell these conditions apart.

The team followed 231 patients with episodic vertigo who met criteria for MD, VM, or both between July 2019 and December 2021. Each patient underwent a specialized MRI to assess the severity of hydrops in the cochlea (for hearing) and vestibule (for balance). Crucially, the researchers did not use the MRI to make the final diagnosis. Instead, they tracked how patients responded to targeted treatments over at least two years—for example, migraine preventives for VM or diuretics and dietary changes for MD. This treatment response served as the study’s diagnostic gold standard, against which the MRI findings were compared.

Clear Patterns Emerge: Hydrops Severity Points to Diagnosis

The results revealed statistically significant differences. In patients whose final diagnosis was Ménière disease, hydrops was a common finding. Grade I (mild) hydrops was most frequent in the cochlea (59.6%), while grade II (more pronounced) hydrops was most common in the vestibule (50.6%). This aligns with the long-held theory that hydrops is a central mechanism in MD.

The pattern for vestibular migraine was strikingly different. No hydrops was found in 58.0% of cochleas and 50.7% of vestibules in VM patients. When hydrops was present, it was overwhelmingly mild (Grade I), seen in 39.1% of cases for both structures. This suggests that in VM, inner ear symptoms like vertigo and aural fullness likely stem from neurological and vascular mechanisms shared with migraine, not from permanent structural fluid shifts in the inner ear.

This imaging evidence helps explain the clinical overlap. A patient with VM might experience ear fullness and mild, transient hydrops due to migraine-related inflammation or blood flow changes. A patient with MD has a more fixed, structural hydrops that correlates with their progressive hearing loss and vertigo attacks. The study also examined patients with features of both conditions (VMMD), whose hydrops patterns fell between the two pure groups.

From Scan to Treatment Plan: Practical Implications

This research moves hydrops imaging from a research tool toward a practical clinical aid. For otologists and neurologists, the findings offer a data-driven rationale for using MRI not to diagnose unilaterally, but to support a clinical suspicion and guide treatment strategy.

A patient presenting with vertigo, tinnitus, and mild headache might receive a tentative diagnosis of vestibular migraine. If an MRI shows significant hydrops, however, it could prompt the clinician to also consider Ménière-targeted therapies earlier, or to monitor hearing more closely. Conversely, the absence of hydrops in a patient suspected of having MD might shift the focus toward migraine management. As the researchers note, treatment response remains the ultimate diagnostic test, but MRI can make the diagnostic journey shorter and more precise.

This precision is vital. An accurate diagnosis directs patients toward more effective treatments—preventive medications and lifestyle triggers for VM, versus salt restriction, diuretics, or intratympanic therapies for MD. Misdiagnosis can lead to years of ineffective treatment and disease progression. The study also reinforces that these are distinct biological entities with different pathways from the cochlea to the cortex, even when symptoms mirror each other.

A New Tool in a Growing Diagnostic Arsenal

The work by Gagnon, Letourneau, and Saliba adds to a growing body of evidence using advanced technology to differentiate auditory and vestibular disorders. It complements other advances, such as research using brain imaging to predict tinnitus treatment success or studies exploring the link between migraine and hidden hearing loss. While the MRI technique used is not yet available in every clinic, it represents a significant step toward objective, biomarker-based diagnosis in neurotology.

For patients, this means hope for fewer diagnostic dead-ends. Understanding that their vertigo and ear symptoms may stem from a migraine brain rather than a hydrops-filled ear can be empowering. It opens up a different, often highly effective, treatment path. As high-resolution MRI becomes more accessible, visualizing endolymphatic hydrops will likely become a standard part of the diagnostic workup for complex vertigo, ensuring patients get the right treatment for their specific condition sooner.

Source: Gagnon C, Letourneau L, Saliba I. Differentiating Ménière Disease and Vestibular Migraine: A Prospective MRI Study of Endolymphatic Hydrops. Otol Neurotol. 2026. doi:10.1097/MAO.0000000000005003. PMID: 42456062.